Jul 26
2021
How Information Technology Helps In Med Tech Research
The main areas of use of biotechnology today are medicine, pharmaceuticals, agriculture, and other industries, where BioTech innovations can reduce the cost of production, speed up the development of vaccines, or model the changes of genomel. But, the development in this area is very expensive, and the necessary research requires a lot of time, and all kind of resources.
The cost of BioTech solutions is also influenced by the availability of technological and human resources. Research centers, special devices, and highly qualified specialists are needed for the development, testing, and implementation of advances in biotechnology and healthcare. The more there are, the lower the cost of producing medtech products due to the ability to scale development. At the same time, it is necessary to demo the statistically representative data, which demands the repetition of experiments and very careful documentation of all the experiments’ work circles, which create additional costs.
It is necessary to increase capacity in research centers through the purchase of modern and productive equipment to reduce the cost of technology. Also, other ways are needed to modernize production facilities, which will help to speed up the Design-Build-Test-Learn cycle. It should be borne in mind that the equipment itself will not help to process and structure huge amounts of data. As one of the way to optimization, artificial intelligence integration can work nowadays. They take the burden off specialists, dismissing the routine work, and in some ways can structurize the documentation flow and research data storage.
Examples of the use of AI and ML in biotechnology
Scientists from Russia and Belarus have developed a special substrate for efficient stem cell growth. This substrate can be used to develop new materials and technologies in the field of regenerative medicine.
According to the representative of the research group, such substrates can be created based on bacterial cellulose, which is produced by the bacteria Acetobacteraceae bacteria, and which is modified with cerium oxide nanoparticles, which give it unique bioactivity and provide accelerated division of stem cells on its surface, which is the main tool of regenerative medicine.
These cells can self-renew, divide through mitosis and differentiate into specialized cells, that is, turn into cells of various organs and tissues. The researchers used special fluorescent stem cells from transgenic mice with a mutation that gives a green glow to all cells in the body. This made it possible to visualize stem cells on a substrate and analyze the process of their accelerated division.
There’s never been a more exciting era in the healthcare IT space than now. The intersection of disruptive technological innovation and a more tech-savvy generation of customers provides endless opportunities across a wide range of medical applications.